Keyphrases
Older Adults
100%
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Disease Entity
100%
Epstein-Barr Virus-positive
100%
Epstein-Barr Virus
50%
Clinical Characteristics
37%
Elderly People
37%
Medical Center
25%
Lymphoma
25%
Confidence Interval
25%
Hazard Ratio
25%
Young Subgroup
25%
International Prognostic Index
25%
Old Age
12%
Advanced Stage
12%
Young Patients
12%
Overall Survival
12%
Non-associated
12%
Age-adjusted
12%
Worse Outcome
12%
Virus Status
12%
Prognostic Impact
12%
Survival Outcomes
12%
Poor Prognostic
12%
Clinical Survival
12%
Extranodal Involvement
12%
De Novo Diffuse Large B-cell Lymphoma
12%
Medicine and Dentistry
Disease
100%
Diffuse Large B-Cell Lymphoma
100%
Epstein Barr Virus
100%
Prevalence
18%
Hazard Ratio
18%
International Prognostic Index
18%
Cohort Analysis
9%
Overall Survival
9%
Pharmacology, Toxicology and Pharmaceutical Science
Epstein-Barr Virus
100%
Diffuse Large B Cell Lymphoma
100%
Disease
100%
Prevalence
18%
Cohort Study
9%
Overall Survival
9%
Biochemistry, Genetics and Molecular Biology
Epstein Barr Virus
100%
B Cell
100%
Prevalence
18%
Cohort Study
9%
Overall Survival
9%
Immunology and Microbiology
B Cell
100%
Epstein Barr Virus
100%
Prevalence
18%
Overall Survival
9%
Psychology
Hazard Ratio
100%
Worse Outcome
50%